Dyslipidaemia in children on renal replacement therapy.
Bonthuis, Marjolein; van Stralen, Karlijn J; Jager, Kitty J; Baiko, Sergey; Jahnukainen, Timo; Laube, Guido F; Podracka, Ludmila; Seeman, Tomás; Tyerman, Kay; Ulinski, Tim; Groothoff, Jaap W; Schaefer, Franz; Verrina, Enrico.
Nephrol Dial Transplant
; 29(3): 594-603, 2014 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-24170813
More hostile dyslipidaemia in chronic kidney disease patients on maintenance haemodialysis than on conservative management.
Vitamin E supplementation improves high-densitiy lipoprotein and endothelial functions in end-stage kidney disease patients undergoing hemodialysisâ©.
ESRD-induced dyslipidemia-Should management of lipid disorders differ in dialysis patients?
The Interconnection Between Immuno-Metabolism, Diabetes, and CKD.
Association between dyslipidemia and residual renal function in patients on chronic peritoneal dialysis.
What is the role of lipid measurements in end-stage renal disease?
Comparing Dialysis Modality and Cardiovascular Mortality in Patients on Hemodialysis and Peritoneal Dialysis.
HMG CoA reductase inhibitors (statins) for dialysis patients.
Association of serum lipids with outcomes in Hispanic hemodialysis patients of the West versus East Coasts of the United States.
Low body mass index and dyslipidemia in dialysis patients linked to elevated plasma fibroblast growth factor 23.